Spinal and Bulbar Muscular Atrophy Clinical Trial
Official title:
A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)
The purpose of this study was to determine if BVS857 is safe, tolerable and increases thigh muscle thickness in patients with spinal bulbar and muscular atrophy (SBMA).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04944940 -
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
|
||
Recruiting |
NCT03555578 -
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
|
||
Completed |
NCT00303446 -
Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
|
Phase 2 | |
Recruiting |
NCT06411912 -
A Study of NIDO-361 in Patients With SBMA
|
Phase 2 | |
Completed |
NCT02156141 -
High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy
|
N/A | |
Active, not recruiting |
NCT05517603 -
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT06169046 -
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
|
Phase 2 |